Connection
Michael Arnold to Osteonectin
This is a "connection" page, showing publications Michael Arnold has written about Osteonectin.
|
|
Connection Strength |
|
 |
|
 |
|
0.031 |
|
|
|
-
Houghton PJ, Kurmasheva RT, Kolb EA, Gorlick R, Maris JM, Wu J, Tong Z, Arnold MA, Chatterjee M, Williams TM, Smith MA. Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(?)) by the Pediatric Preclinical Testing Program (PPTP). Pediatr Blood Cancer. 2015 Jul; 62(7):1214-21.
Score: 0.031